SUNNYVALE, Calif., Jan. 17, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its second quarter of fiscal 2013, ended December 31, 2012 on Wednesday, February 6, 2013 after the market closes.
A conference call to review the results will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer.
The conference call dial-in numbers are 1-866-761-0749 (USA) or 1-617-614-2707 (International), Conference ID: 63591669. In addition, a dial-up replay of the conference call will be available beginning February 6, 2013 at 5:00 p.m. PST/8:00 p.m. EST and ending on February 13, 2013. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 63531003.
A live webcast of the call will also be available from the Investor Relations section of the corporate website at http://www.accuray.com/investors. A webcast replay can be accessed on the corporate website beginning Wednesday, February 6, 2013 at approximately 5:00 p.m. PST/8:00 p.m. EST. The replay will remain available until Accuray announces its results for the third quarter of fiscal 2013, ending March 31, 2013.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.
|
Contacts:
|
Investor Contact:
Tom Rathjen
Vice President, Investor Relations
+1 (408) 789-4458
trathjen@accuray.com
|
Media Contact:
Stephanie Tomei
Director, Corporate Communications
+1 (408) 789-4234
stomei@accuray.com
|
SOURCE Accuray Incorporated
